United Therapeutics Corporation v. Liquidia Technologies, Inc.
Opinion
Case: 22-2133 Document: 28 Page: 1 Filed: 11/18/2022
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit UNITED THERAPEUTICS CORPORATION, Appellant
v.
LIQUIDIA TECHNOLOGICS, INC., Appellee
2022-2133
Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770. --------------------------------------------------
LIQUIDIA TECHNOLOGICS, INC., Appellant
UNITED THERAPEUTICS CORPORATION, Appellee
2022-2174 Case: 22-2133 Document: 28 Page: 2 Filed: 11/18/2022
2 BRUMFIELD V. IBG LLC
Appeal from the U n i t e d S t a t e s Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770.
ON MOTION
ORDER Upon consideration of the party’s motion to voluntarily dismiss Appeal No. 2022-2174,
IT IS ORDERED THAT: (1) The motion is granted. Appeal No. 2022-2174 is DISMISSED under Fed. R. App. P. 42 (b). (2) Each side shall bear their own costs with respect to Appeal No. 2022-2174. (3) Appeal No. 2022-2174 is deconsolidated from Appeal No. 2022-2133, and the revised caption is reflected above.
November 18, 2022 FOR THE COURT Date
/s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court
ISSUED AS A MANDATE (only as to Appeal No. 2022-2174): November 18, 2022
Free access — add to your briefcase to read the full text and ask questions with AI
United Therapeutics Corporation v. Liquidia Technologies, Inc. (United Therapeutics Corporation v. Liquidia Technologies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.